对于抗性卵巢癌的治疗范式的演变:更新叙事审查
Hao Lin1, Chen-Hsuan Wu1, Hung-Chun Fu1
1Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Taiwanese journal of obstetrics & gynecology
|July 14, 2024
概括
新型疗法正在改善白金耐药卵巢癌 (PROC) 的治疗结果. 基于生物标志物的方法,包括抗体-药物合物和WEE1抑制剂,为PROC患者提供个性化的治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗性卵巢癌 (PROC) 的定义是根据基化疗的六个月内疾病的进展.
- 从历史上看,PROC治疗选择是有限的,预后不佳,依赖于与贝瓦西祖马布结合的非白金药物.
- 最近的进展为PROC引入了新的治疗策略,改善了治疗范式.
研究的目的:
- 总结PROC新型生物标志物驱动的治疗方法的关键临床发现.
- 突出抗性卵巢癌新兴治疗方法的疗效和安全性.
- 讨论生物标志物在个性化PROC治疗策略中的作用.
主要方法:
- 对PROC的新型治疗方法的临床发现的审查.
- 探索包括化疗,PARP抑制剂和免疫治疗在内的组合.
- 专注于针对叶酸受体α和WEE1抑制剂的抗体-药物结合物,如阿达沃谢蒂布.
主要成果:
- 针对叶酸受体α的抗体 - 药物结合体对PROC.有希望.
- 诸如阿达沃谢蒂布 (adavosertib) 等WEE1抑制剂会诱导DNA损伤,在TP53突变癌症中可能更有效.
- 生物标志物测试 (叶酸受体α表达,TP53突变) 可以指导个性化治疗选择.
结论:
- 新型生物标记驱动疗法在治疗PROC方面取得了重大进展.
- 使用叶酸受体α和TP53状态等生物标志物的个性化治疗方法正在出现.
- 对这些新型药物和生物标志物的持续研究对于优化PROC患者的治疗结果至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K